early detection Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data Premium The company presented its first analyses answering crucial questions about real-world performance and impact on patients' well-being and healthcare utilization. Burning Rock Embarks on Large-Scale Study for 22-Cancer Screening Assay Premium The company plans to recruit about 12,000 individuals, split between cancer cases and controls, to train and test a newly developed 22-cancer early detection test. Burning Rock Q1 Revenues Rise 58 Percent The Guangzhou, China-based company said it tested 7,716 patients through its central lab during the quarter, driving its overall revenue growth. Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing Premium The company expects to launch testing for advanced cancer patients this year, with studies now running to expand to cancer screening and monitoring applications. Viome Forays Outside Molecularly Informed DTC Wellness Testing With Oral Cancer Assay Premium The firm also hopes to use its metatranscriptomics approach to develop diagnostics and therapeutics for a variety of other disease areas. Apr 15, 2021 Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches Premium Apr 11, 2021 NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths Mar 25, 2021 Genetron Health Updates Data from Prospective Liquid Biopsy Liver Cancer Screening Study Premium Mar 25, 2021 Genetron Health Q4 Revenues Up 30 Percent Mar 12, 2021 GeneFirst Aims to Prove Clinical Feasibility for ATOM-Seq Colorectal Cancer Detection Test Premium Mar 11, 2021 Burning Rock Q4 Revenues Rise 50 Percent Feb 12, 2021 Naveris Explores New Applications for ctDNA HPV Head and Neck Cancer Test Premium Jan 12, 2021 Delfi Diagnostics Details Plans to Advance Fragmentomic Method for Early Cancer Detection Premium Jan 12, 2021 Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test Jan 11, 2021 Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 Premium Jan 6, 2021 Genetron Health to Partner With Sino Biopharm Subsidiary to Comarket Liver Cancer Test in China Nov 30, 2020 Genetron Health, Wuxi Government Form Joint Venture for Liver Cancer Screening Test Nov 2, 2020 Bluestar Genomics Eyes Pan-Cancer Early Detection With Epigenetic Assay Technology Premium Oct 1, 2020 AnPac Bio-Medical Nabs $7M Equity Investment for Cancer Early Detection Platform Sep 22, 2020 UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal Sep 21, 2020 JP Morgan Downgrades Illumina to Neutral on Grail Deal Sep 21, 2020 Illumina to Acquire Grail for $8B in Cash and Stock Sep 18, 2020 MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention Premium Sep 14, 2020 Grail Plans Additional Liquid Biopsy Tests for Cancer Detection, Monitoring Premium Sep 10, 2020 Cowen Initiates Coverage of DermTech With Outperform Rating Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.